Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06644261 · ClinicalTrials.gov registry record · Phase 4

Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia

A Phase 4 study of Chronic Pelvic Pain Syndrome and Pudendal Neuralgia, sponsored by University of Louisville.

Recruiting
Registry status
Phase 4
Development phase
40
Enrollment target
1
Study location

NCT06644261: Recruiting Phase 4 study of Chronic Pelvic Pain Syndrome and Pudendal Neuralgia, sponsored by University of Louisville.

NCT06644261 is a Phase 4 study of Chronic Pelvic Pain Syndrome and Pudendal Neuralgia that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 40 participants, below the 193-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06644261, a Phase 4 study of Chronic Pelvic Pain Syndrome and Pudendal Neuralgia, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
Phase 4
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Chronic pain affecting the pelvic and urogenital area is a major clinical problem and can have a profound impact on quality of life and health care costs. Pelvic pain arising from entrapment or neuropathy of the pudendal nerve is known as pudendal neuralgia, which results in chronic perineal pain. This pain syndrome is difficult to diagnose and patients with pudendal neuralgia may present to providers with refractory chronic pelvic pain. Pudendal nerve infiltration or pudendal nerve block (PNB) serves as a diagnostic tool and treatment modality for patients with this condition. To date, there are no published randomized controlled trials comparing imaging-guided PNB to transvaginal finger-guided PNB. While one can assume that image-guided nerve blocks will provide better accuracy for injection and potentially better efficacy in pain relief as a result, no published data exists comparing the outcomes and efficacy between modalities. The purpose of this prospective, non-inferiority, randomized controlled trial is to compare the efficacy of pain relief from bilateral transvaginal finger-guided pudendal nerve block versus bilateral fluoroscopy-guided trans gluteal pudendal nerve block for patients with pudendal neuralgia.

Primary Outcome

VAS will be obtained at baseline, post-procedure, weekly until 6 weeks, scale is 0-100 mm with higher scores indicated more pain severity

Interventions

  • DRUG Bupivacaine injection

Study Locations (1)

Kentucky

  • University of Louisville Division of Urogynecology and Reconstructive Pelvic Surgery - Louisville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-06-27
Est. Completion 2029-07-01
Phase Phase 4
University of Louisville

217 total trials

What NCT06644261 shows while recruiting

NCT06644261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 193-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (79% lower).

The record links to 2 conditions, with Chronic Pelvic Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Bupivacaine injection is the first listed.

NCT06644261 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT06644261 about?

NCT06644261 is a clinical study titled "Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia". Chronic pain affecting the pelvic and urogenital area is a major clinical problem and can have a profound impact on quality of life and health care costs. Pelvic pain arising from entrapment or neuropathy of the pudendal nerve is known as pudendal neuralgia, which results in chronic perineal pain. T...

What is the current status of trial NCT06644261?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2024-06-27. Estimated completion is 2029-07-01.

What conditions does trial NCT06644261 study?

This clinical trial studies the following conditions: Chronic Pelvic Pain Syndrome, Pudendal Neuralgia.

What interventions are being tested in trial NCT06644261?

The interventions under investigation include: Bupivacaine injection (DRUG).

Who is sponsoring clinical trial NCT06644261?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06644261 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pelvic Pain Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06644261's enrollment target sits among peer trials

40 9th of 11 higher than 2 of 11 other Chronic Pelvic Pain Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pelvic Pain Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06644261, the US trial registry maintained by the National Library of Medicine. NCT06644261 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.